FDA Inspection 1337350 — Pharmaron (Ningbo) Technology Development Co., Ltd.
The FDA completed an inspection of Pharmaron (Ningbo) Technology Development Co., Ltd. on Aug 14, 2026 in Ningbo. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 14, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ningbo (China)